CCM
Concord Medical Services Holdings Limited
There isn't enough reported data to score CCM yet.
LLY
Eli Lilly and Company
LLY's fundamentals are strong: revenue grew 46% and it turned 23% of its revenue into free cash flow. At 46x earnings, it's trading in line with its usual 48x. Analysts expect that strong growth to continue.
CCM Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Weak |
CCM's profitability and balance sheet are currently under pressure. There isn't enough data to rate its revenue and cash flow.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
CCM PE Valuation
CCM has no meaningful PE right now: it lost money over the past year.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
CCM Forward outlook
There aren't enough analyst estimates for CCM to show an outlook.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
CCM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | -$0.11 | +$0.24 |
| Q4 2024 | -$0.35 | +$3.06 |
| Q4 2023 | -$3.41 | +$2.20 |
| Q4 2020 | -$7.67 | -$1.31 |
| Q4 2019 | -$6.36 | -$2.22 |
| Q4 2018 | -$4.14 | -$0.85 |
| Q4 2017 | -$3.29 | -$0.29 |
| Q4 2016 | -$3.00 | -$2.13 |
CCM is still losing money, but far less than before: $0.11 per share over the past year, against $7.67 at its worst in late 2020.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over CCM in the latest year-over-year earnings comparison.
CCM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $69.1M | +20% |
| Q4 2024 | $57.6M | -29% |
| Q4 2023 | $80.6M | +14% |
| Q4 2022 | $70.8M | -2.8% |
| Q4 2021 | $72.9M | +118% |
| Q4 2020 | $33.5M | +12% |
| Q4 2019 | $29.8M | +3.9% |
| Q4 2018 | $28.6M | -42% |
CCM's revenue is growing: $69M last quarter, down 5.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -57% | +38 points |
| Q4 2024 | -139% | +3.1 points |
| Q4 2023 | -86% | +134 points |
| Q4 2022 | -111% | +46 points |
| Q4 2021 | -94% | -30 points |
| Q4 2020 | -142% | -105 points |
| Q4 2019 | -220% | -220 points |
| Q4 2018 | -157% | -187 points |
CCM's operating margin was −57% last quarter, up 38 points from the same quarter a year ago.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over CCM in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY's operating margin was 34% last quarter, down 6.6 points from the same quarter a year ago.
CCM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$38.7M | +$43.6M |
| Q4 2024 | -$82.3M | -$23.9M |
| Q4 2023 | -$58.4M | +$7.5M |
| Q4 2022 | -$66M | +$29.8M |
| Q4 2021 | -$95.8M | -$36.1M |
| Q4 2020 | -$59.7M | +$4.5M |
| Q4 2019 | -$64.2M | -$33.6M |
| Q4 2018 | -$30.6M | -$21M |
CCM has burned cash in most quarters: −$245M over the past year, against −$250M the year before.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY generated $19.7B in free cash flow over the past year, up 112% from the year before.
CCM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +900% | +118M shares |
| 3 years | +733% | +115M shares |
CCM has 131M diluted shares, up 900% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2018 | — |
| Q4 2017 | — |
| Q4 2016 | $4.6M |
| Q4 2015 | $3M |
| Q4 2013 | $902,679 |
| Q4 2012 | $6.5M |
| Q4 2011 | $1M |
| Q4 2009 | — |
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over CCM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
CCM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2015 | 4.7x | High |
| Q4 2014 | 1.1x | Healthy |
| Q4 2013 | 2.2x | Moderate |
| Q4 2012 | 2.3x | Moderate |
CCM's net debt is about 4.7 years of its operating earnings (EBITDA).
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
CCM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.7 | Neutral |
| Stochastic | 28.6 | Neutral |
CCM's weekly RSI is 44 (neutral) and its Stochastic is 29 (neutral).
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
CCM PE vs Healthcare Sector
CCM has no meaningful PE right now: it lost money over the past year.
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
CCM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.65 | 2.7% below |
| 20 week MA | $4.17 | 15% below |
| 50 week MA | $4.24 | 16% below |
| 100 week MA | $4.79 | 26% below |
| 200 week MA | $7.27 | 51% below |
CCM is in a downtrend: it's below all five of its weekly moving averages, and 51% below its 200-week average.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over CCM on trend strength, trading above more of its moving averages.
CCM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $27.3 | $29.1 | +6.6% |
| 2021 | $29.1 | $20.5 | -30% |
| 2022 | $20.5 | $16.6 | -19% |
| 2023 | $16.6 | $11.0 | -34% |
| 2024 | $11.0 | $5.02 | -54% |
| 2025 | $5.02 | $3.76 | -25% |
| 2026 YTD | $3.76 | $3.55 | -5.6% |
CCM has finished five years in a row lower, and it's down 5.6% so far in 2026.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over CCM on returns for 2026, with the stronger performance.